← Leaderboards
Timothy Yen
University Of Pennsylvania
$8,121,070
Attributed
$8,428,101
Total exposure
10
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $688.6K · FY2005–22$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$8,428,101 · 10
By mechanism
R01$5,154,967 · 3
R21$1,274,198 · 3
P01$788,047 · 1
S10$599,789 · 1
P30$424,100 · 1
R03$187,000 · 1
Top collaborators
- Alfonso Bellacosa4 shared
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Michael Lampson$12,096,625
- Graca Graca Raposo$4,003,633
- Wei Guo$15,763,941
- Benhur Lee$26,036,912
- Ben E. Black$15,469,500
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsBaseCell LineHela CellsComplexMolecularMalignant NeoplasmsCancer CellSiteMammalian CellIn VitroNovel StrategiesInhibitor/AntagonistStructureExhibitsEpigenetic ProcessPharmaceutical PreparationsBinding ProteinsPhosphorylationTumorChromosome SegregationProteinsIn VivoPrograms
Grant awards (39)
Identification of first-in-class epigenetic inhibitors that target Thymine DNA Glycosylase (TDG) for future precision therapy of metastatic melanoma$93,500
R03 · FY2022 · CA
Identification of first-in-class epigenetic inhibitors that target Thymine DNA Glycosylase (TDG) for future precision therapy of metastatic melanoma$93,500
R03 · FY2021 · CA
Shared Resource: Biological Imaging Facility$26,461
P30 · FY2021 · CA · contact PI
Shared Resource: Biological Imaging Facility$82,219
P30 · FY2020 · CA · contact PI
Shared Resource: Biological Imaging Facility$8,696
P30 · FY2020 · CA · contact PI
Shared Resource: Biological Imaging Facility$76,921
P30 · FY2019 · CA · contact PI
Multiphoton microscopy system$599,789
S10 · FY2018 · OD · contact PI
Shared Resource: Biological Imaging Facility$72,015
P30 · FY2018 · CA · contact PI
Shared Resource: Biological Imaging Facility$10,871
P30 · FY2018 · CA · contact PI
Shared Resource: Biological Imaging Facility$5,968
P30 · FY2018 · CA · contact PI
Shared Resource: Biological Imaging Facility$72,012
P30 · FY2017 · CA · contact PI
TDG as a novel target to enhance gemcitabine killing of pancreatic cancer cells$194,119
R21 · FY2016 · CA
Shared Resource: Biological Imaging Facility$68,937
P30 · FY2016 · CA · contact PI
TDG as a novel target to enhance gemcitabine killing of pancreatic cancer cells$232,943
R21 · FY2015 · CA
Characterization of Drug Survival by Pancreatic Cancer Cells in vitro and in vivo$232,943
R21 · FY2015 · CA · contact PI
Chemosensitization of Pancreatic Cancer Cells by Curcumin and Vitamin D Receptor$225,955
R21 · FY2014 · CA · contact PI
Characterization of Drug Survival by Pancreatic Cancer Cells in vitro and in vivo$194,119
R21 · FY2014 · CA · contact PI
Chemosensitization of Pancreatic Cancer Cells by Curcumin and Vitamin D Receptor$194,119
R21 · FY2013 · CA · contact PI
Mechanism of Mitotic Checkpoint in Mammalian Cells$376,260
R01 · FY2011 · GM · contact PI
Mechanism of Mitotic Checkpoint in Mammalian Cells$380,061
R01 · FY2010 · GM · contact PI
Mechanism of Mitotic Checkpoint in Mammalian Cells$125,322
R01 · FY2010 · GM · contact PI
Kinetochore Structure and Function$80,034
R01 · FY2010 · GM · contact PI
Mechanism of Mitotic Checkpoint in Mammalian Cells$383,900
R01 · FY2009 · GM · contact PI
Mechanism of Mitotic Checkpoint in Mammalian Cells$381,700
R01 · FY2008 · GM · contact PI
Kinetochore Structure and Function$406,296
R01 · FY2007 · GM · contact PI
Mechanism of Mitotic Checkpoint in Mammalian Cells$74,582
R01 · FY2007 · CA · contact PI
Mechanism of Mitotic Checkpoint in Mammalian Cells$338,423
R01 · FY2005 · CA
Kinetochore Structure and Function$412,736
R01 · FY2004 · GM
Mechanism of Mitotic Checkpoint in Mammalian Cells$340,425
R01 · FY2004 · CA
Kinetochore Structure and Function$400,813
R01 · FY2003 · GM
Mechanism of Mitotic Checkpoint in Mammalian Cells$335,441
R01 · FY2003 · CA
Kinetochore Structure and Function$389,238
R01 · FY2002 · GM
ROLE OF ATAXIA TELANGIECTASIA IN CHECKPOINT CONTROL$140,673
P01 · FY2002 · CA
Kinetochore Structure and Function$385,500
R01 · FY2001 · GM
ROLE OF ATAXIA TELANGIECTASIA IN CHECKPOINT CONTROL$140,673
P01 · FY2001 · CA
KINETOCHORE STRUCTURE/FUNCTION$344,236
R01 · FY2000 · GM
ROLE OF ATAXIA TELANGIECTASIA IN CHECKPOINT CONTROL$183,014
P01 · FY2000 · CA
ROLE OF ATAXIA TELANGIECTASIA IN CHECKPOINT CONTROL$183,014
P01 · FY2000 · CA
ROLE OF ATAXIA TELANGIECTASIA IN CHECKPOINT CONTROL$140,673
P01 · FY2000 · CA